Charles River Associates Expands Life Sciences Practice with Appointment of Two Seasoned Industry Leaders Charles River Associates (NASDAQ: CRAI), a globally recognized leader in economic, financial, and management consulting, has announced a strategic expansion of its Life Sciences Practice with…
Roche’s Susvimo Shows Durable Vision Preservation Over Five Years with Twice-Yearly Treatment in Neovascular AMD Roche has released compelling new long-term data highlighting the extended efficacy, safety, and durability of its innovative eye implant therapy, Susvimo® (ranibizumab injection), for individuals…
Altasciences and VoxCell BioInnovation Forge Strategic Partnership to Revolutionize Preclinical Drug Development with 3D Bioprinted Human Tissue Models In a move poised to reshape the landscape of early-stage drug development, Altasciences, a fully integrated drug development solution provider, and VoxCell…
Labcorp Earns IVDR CE-Marking for PGDx elio™ tissue complete, Paving the Way for Expanded Personalized Oncology Testing Across Europe In a milestone achievement that advances the accessibility of precision oncology in Europe, Labcorp (NYSE: LH), a global leader in comprehensive…
Simulations Plus and Polish Academy Scientists Validate AI-Powered Drug Design Models in Breakthrough Discovery Targeting Inflammation and Immune Regulation Simulations Plus, Inc. (Nasdaq: SLP), a prominent developer of modeling and simulation software for the biopharmaceutical industry, in collaboration with the…
Centauri Therapeutics Secures Additional $5.1M from CARB-X to Propel Lead Antibacterial Candidate ABX-01 Into First-in-Human Trials Centauri Therapeutics Limited, an innovative immunotherapy company leveraging a novel platform for combating infectious diseases, announced today it has been awarded an additional $5.1…
Flatiron Health Triples Global Oncology Research Network to Power Multinational Real-World Evidence Generation Flatiron Health, a healthtech company pioneering the use of real-world data (RWD) to transform cancer care and accelerate oncology research, has announced a significant milestone: the tripling…
Aptar’s Nasal Delivery System Helps Validate Breakthrough Alzheimer’s Treatment in Wake Forest Study In a major advancement for Alzheimer’s research and the evolving field of drug delivery science, AptarGroup, Inc. (NYSE: ATR), a global leader in the design and manufacturing…
CVS Health Unveils New Workforce Innovation and Talent Center in Columbus to Empower Local Communities Through Job Training and Health Services In a powerful step toward strengthening community health and economic resilience, CVS Health® (NYSE: CVS) has officially opened the…
ReAlta Life Sciences Publishes Preclinical Data Showing RLS-0071 Reduces Brain Inflammation in Neonatal Hypoxic-Ischemic Encephalopathy Model ReAlta Life Sciences, Inc., a clinical-stage biopharmaceutical company advancing therapies that rebalance the body’s inflammatory response, has announced the publication of new preclinical findings…
Takeda Gains FDA 510(k) Clearance for HyHub™ and HyHub™ Duo to Enhance HYQVIA® Administration Experience for Patients with Primary Immunodeficiency and CIDP Takeda (TSE:4502/NYSE:TAK), a global biopharmaceutical leader, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)…
WHO Strongly Condemns Attacks on Staff Shelter and Warehouse in Gaza as Humanitarian Health Operations Reach Breaking Point The World Health Organization (WHO) has issued a forceful condemnation of recent assaults on its facilities and staff in Deir al Balah,…